AAAAAA
Results:
1-7
|
Results: 7
Authors:
Kamali, M
Kelly, L
Gervin, M
Browne, S
Larkin, C
O'Callaghan, E
Citation: M. Kamali et al., Psychopharmacology: Insight and comorbid substance misuse and medication compliance among patients with schizophrenia, PSYCH SERV, 52(2), 2001, pp. 161
Authors:
Hoult, DI
Saunders, JK
Sutherland, GR
Sharp, J
Gervin, M
Kolansky, HG
Kripiakevich, DL
Procca, A
Sebastian, RA
Dombay, A
Rayner, DL
Roberts, FA
Tomanek, B
Citation: Di. Hoult et al., The engineering of an interventional MRI with a movable 1.5 Tesla magnet, J MAGN R I, 13(1), 2001, pp. 78-86
Authors:
Gervin, M
Bamford, L
Smyth, BP
Keenan, E
Citation: M. Gervin et al., Heroin smoking by "chasing the dragon" in young opiate users in Ireland: stability and associations with use to "come down" off "Ecstasy", J SUBST ABU, 20(4), 2001, pp. 297-300
Authors:
Browne, S
Clarke, M
Gervin, M
Lane, A
Waddington, JL
Larkin, C
O'Callaghan, E
Citation: S. Browne et al., Determinants of neurological dysfunction in first episode schizophrenia, PSYCHOL MED, 30(6), 2000, pp. 1433-1441
Authors:
Browne, S
Clarke, M
Gervin, M
Waddington, JL
Larkin, C
O'Callaghan, E
Citation: S. Browne et al., Determinants of quality of life at first presentation with schizophrenia, BR J PSYCHI, 176, 2000, pp. 173-176
Authors:
Kamali, M
Kelly, L
Gervin, M
Browne, S
Larkin, C
O'Callaghan, E
Citation: M. Kamali et al., The prevalence of comorbid substance misuse and its influence on suicidal ideation among in-patients with schizophrenia, ACT PSYC SC, 101(6), 2000, pp. 452-456
Authors:
Gervin, M
Browne, S
Garavan, J
Roe, M
Larkin, C
O'Callaghan, E
Citation: M. Gervin et al., Dysphoric subjective response to neuroleptics in schizophrenia: relationship to extrapyramidal side effects and symptomatology, EUR PSYCHIA, 14(7), 1999, pp. 405-409
Risultati:
1-7
|